Tag: Chemotherapy
Childhood Cancer Treatment, Genetics Contribute to Subsequent Neoplasm Risk
Contributions quantified for subsequent neoplasms in childhood cancer survivors
Dostarlimab + Chemo Beneficial for Advanced, Recurrent Endometrial Cancer
Longer mean duration of quality-adjusted time without symptoms of disease progression or toxicity of treatment seen with dostarlimab
Nodal Irradiation Does Not Reduce Recurrence, Death for ypN0 Breast Cancer
No reduction seen in risk with adjuvant regional nodal irradiation among patients with node-positive breast cancer who reached ypN0 status after neoadjuvant chemo
ASCO: Disease-Free Survival Prolonged With Exercise Program in Colon Cancer
Improved survival seen with structured program in patients with resected colon cancer who have completed adjuvant chemo
ASCO: Encorafenib + Cetuximab + Chemo Lengthens Survival in Metastatic CRC
Significantly longer progression-free and overall survival seen in patients with BRAF V600E mutations
Adding Bevacizumab to Chemo Beneficial in High-Risk Ovarian Cancer
Real-world benefit seen with addition of bevacizumab to first-line chemotherapy for patients with high‐risk prognostic factors
Exercise Helps Reduce Side Effects From Cancer Treatment
Some benefits include mitigation of cardiac toxicity, peripheral neuropathy, cognitive impairment, and dyspnea
Melphalan/Hepatic Delivery System Beneficial for Metastatic Uveal Melanoma
Melphalan/HDS efficacious, has favorable risk-benefit profile for unresectable metastatic uveal melanoma
Brain Functional Networks Affected by Neoadjuvant Chemo in Breast Cancer
Increased global efficiency, as well as decreased characteristic path length and altered nodal centralities, seen on functional MRI
ASTRO Issues Clinical Guideline for Use of Radiation Therapy in Anal Cancer
For most patients, definitive treatment with combined modality therapy is recommended
